Hemgenix Interactions
There are 295 drugs known to interact with Hemgenix (etranacogene dezaparvovec), along with 2 disease interactions. Of the total drug interactions, 7 are major, and 288 are moderate.
- View all 295 medications that may interact with Hemgenix
- View Hemgenix disease interactions (2)
Most frequently checked interactions
View interaction reports for Hemgenix (etranacogene dezaparvovec) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- apremilast
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Breyanzi (lisocabtagene maraleucel)
- Brilinta (ticagrelor)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
- Brukinsa (zanubrutinib)
- Bylvay (odevixibat)
- Cabenuva (cabotegravir / rilpivirine)
- Cablivi (caplacizumab)
- Calquence (acalabrutinib)
Hemgenix disease interactions
There are 2 disease interactions with Hemgenix (etranacogene dezaparvovec) which include:
Report options
More about Hemgenix (etranacogene dezaparvovec)
- Hemgenix consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Qfitlia
Qfitlia is used for hemophilia a, hemophilia a with inhibitors, hemophilia b, hemophilia b with ...
Hympavzi
Hympavzi (marstacimab-hncq) may be used to prevent or reduce the frequency of bleeding episodes ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Idelvion
Idelvion (coagulation factor ix recombinant, albumin fusion protein) is a long-acting, injectable ...
BeneFix
BeneFix (coagulation factor IX) is a once-weekly, injectable, treatment for hemophilia B that may ...
Profilnine
Profilnine is used for factor ix deficiency, factor vii deficiency, hemophilia a with inhibitors ...
Alprolix
Alprolix is used in hemophilia B to help control and prevent bleeding, it is a coagulation Factor ...
NovoSeven RT
NovoSeven RT (coagulation Factor VIIa, recombinant) is an injectable, coagulation factor VIIa that ...
Alphanine SD
Alphanine SD is used for factor ix deficiency, hemophilia b
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
